esb世博网

En

中文简体

中文繁体

Our Company

Back

Our Company

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China

About Company
Leadership
Honor
Brand Culture
Member Companies

Fosun Pharma is patient-centered and clinical needs-oriented. The company continuously enriches its innovative product pipeline through independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma improves the research and clinical development capabilities of FIC (First-in-class) and BIC (Best-in-class) new drugs as well as accelerates the R&D and launch of innovative technologies and products.
Our Business

Back

Our Business

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Group Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.

Pharmaceutical Manufacturing
Vaccines
Medical Devices
Medical Diagnosis
Healthcare Services
Pharmaceutical Distribution And Retail

Fosun Pharma is patient-centered and clinical needs-oriented. The company enriches its innovative product pipeline through diversified and multi-level cooperation models such as independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma has formed technological platforms for innovative small molecule drugs, antibody drugs, and cell therapy with a focus on key disease areas including oncology and immunomodulation, metabolism and digestive system, and central nervous system. Fosun Pharma also vigorously explores cutting-edge technologies, such as RNA, oncolytic viruses, gene therapy and PROTAC, to enhance its innovation capabilities.
R&D

Back

R&D

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China.

Global R&D Center
R&D Pipeline
Innovation Platform
Clinical Development
R&D News

Guided by innovation and internationalization, the company continuously enriches its innovative product pipeline through diversified and multi-level cooperation models such as independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma improves the research and clinical development capabilities of FIC (First-in-class) and BIC (Best-in-class) new drugs as well as accelerates the R&D and launch of innovative technologies and products.
Sustainability

Back

Sustainability

In pursuit of sustainable development of talents and products is the social responsibility concept of Fosun Pharma.

Social Responsibility Strategy
Special Fund For Fosun Pharma Health Care Initiative
Social Welfare
CSR News
Relevant Policies
Social Responsibility Report Download
Environmental, Social And Governance Report Download

Fosun Pharma has incorporated the sustainable development strategy into its overall development, and established a sound sustainable development management system. It has set up a corporate social responsibility management committee and an environmental, social and governance (ESG) committee under the board of directors to promote the sustainable development of the Group. Moreover, a sound communication mechanism between stakeholders has been established to continuously improve their satisfaction, maintain its competitiveness in sustainable development, and lead the development of the industry.
Investor Relations

Back

Investor Relations

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China.

Announcements
Corporate Governance
Financial Report
Investor Presentation Materials
FAQS
Investor Contact

Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196.SH, 02196.HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Group Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.
News

Back

News

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China.

Press Release
Member Companies News
Media Resources
Media Contact

Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.
Careers

Back

Careers

Some top talent with strong entrepreneurship gathers here with us.

Talent Concept
Incentives
Life At Fosun Pharma

We are looking for people that recognize and practice our cultural values, and can learn fast to create continuous value; possess profound professional knowledge of the industry, a wide vision of different regions, and global-level expertise in a certain field. We will also be committed to cultivating international top talent with outstanding performance and great potential.

Financial Reports

: ANNUAL REPORT 2022（H SHARES）

: ANNUAL REPORT 2021（H SHARES）

: ANNUAL REPORT 2020（H Shares）

: ANNUAL REPORT 2019（H Shares）

2014-09-10
Interim Report 2014 (H Shares)
2014-04-29
2014 FIRST QUARTERLY REPORT (H Shares)
2014-04-23
ANNUAL REPORT 2013 (H Shares)
2013-10-30
2013 THIRD QUARTERLY REPORT (H Shares)
2013-09-12
Interim Report 2013 (H Shares)
2013-04-29
ANNUAL REPORT 2012 (H shares)
2012-08-28
Abstract of 1H2012 Report
2012-08-28
Full text of 1H2012 Report

Total：63 Home Previous Page 1 2 3 4 5 6 7 8 Next Page Last The Number Of Pages：5/8 GO

_{^{<dd id='hDr2i'><tbody id='MTKFh'><td id='BFDGj'><optgroup id='Vflvn'><strong id='jG760'></strong></optgroup><address id='d5MDe'><ul id='XJZsu'></ul></address><big id='np7Et'></big></td><table id='CqTMr'></table></tbody><pre id='IeTzz'></pre></dd><span id='sQuVs'><b id='LHv2f'></b></span>}}


<dfn id='65IZp'><optgroup id='0RhuN'></optgroup></dfn><tfoot id='CvWI0'><bdo id='vHXW6'><div id='mjqGX'></div><i id='3VMGx'><dt id='pclrr'></dt></i></bdo></tfoot>

_{<fieldset id='hpAsC'></fieldset>}

esb世博网

Our Company

Our Business

R&D

Sustainability

Investor Relations

News

Careers

Financial Reports

ANNUAL REPORT 2022（H SHARES）

ANNUAL REPORT 2021（H SHARES）

ANNUAL REPORT 2020（H Shares）

ANNUAL REPORT 2019（H Shares）